Sfoglia per Autore
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders
2018-01-01 Barbaraci, Carla; Dichiara, Maria; Turnaturi, Rita; Fallica Antonino, N; Arena, Emanuela; Prezzavento, Orazio; Amata, Emanuele; Marrazzo, Agostino
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors.
file da validare2018-01-01 Dichiara, M; Modica, Mn; Leonardi, C; Margani, F; Ciaffaglione, V; Fallica, An; Floresta, G; Gentile, D; Cosenza, J; Pittalà, V.
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents
2019-01-01 Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, Guglielmo; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
2019-01-01 Intagliata, Sebastiano; Salerno, Loredana; Ciaffaglione, Valeria; Leonardi, Carmen; Fallica, ANTONINO NICOLO'; Carota, Giuseppe; Amata, Emanuele; Marrazzo, Agostino; Pittalà, Valeria; Romeo, Giuseppe
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region
2020-01-01 Floresta, Giuseppe; Fallica, Antonino N.; Romeo, Giuseppe; Sorrenti, Valeria; Salerno, Loredana; Rescifina, Antonio; Pittalà, Valeria
The potential role of sildenafil in cancer management through epr augmentation
2021-01-01 Haider, M.; Elsherbeny, A.; Pittala, V.; Fallica, A. N.; Alghamdi, M. A.; Greish, K.
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
2021-01-01 Fallica, Antonino N; Pittalà, Valeria; Modica, Maria N; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Helal, Mohamed A; Intagliata, Sebastiano
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes
2021-01-01 Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V.
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes
2021-01-01 Floresta, G.; Fallica, A. N.; Salerno, L.; Sorrenti, V.; Pittala, V.; Rescifina, A.
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation
2021-01-01 Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S.
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity
2021-01-01 Fallica, A. N.; Sorrenti, V.; D'Amico, A. G.; Salerno, L.; Romeo, G.; Intagliata, S.; Consoli, V.; Floresta, G.; Rescifina, A.; D'Agata, V.; Vanella, L.; Pittala, V.
The Promise of Nanotechnology in Personalized Medicine
2022-01-01 Alghamdi, M. A.; Fallica, A. N.; Virzi, N.; Kesharwani, P.; Pittala, V.; Greish, K.
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects
2022-01-01 Fallica, Antonino N; Ciaffaglione, Valeria; Modica, Maria N; Pittalà, Valeria; Salerno, Loredana; Amata, Emanuele; Marrazzo, Agostino; Romeo, Giuseppe; Intagliata, Sebastiano
Targeting del sistema enzimatico dell'eme ossigenasi come nuovo approccio nella terapia antitumorale
2022-04-08 Fallica, ANTONINO NICOLO'
Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections
2023-01-01 Virzi, N. F.; Fallica, A. N.; Romeo, G.; Greish, K.; Alghamdi, M. A.; Patane, S.; Mazzaglia, A.; Shahid, M.; Pittala, V.
Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer
2024-01-01 Consoli, Valeria; Fallica, Antonino N.; Virzì, Nicola F.; Salerno, Loredana; Intagliata, Sebastiano; Sorrenti, Valeria; Greish, Khaled; Giuffrida, Alessandro; Vanella, Luca; Pittalà, Valeria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders | 1-gen-2018 | Barbaraci, Carla; Dichiara, Maria; Turnaturi, Rita; Fallica Antonino, N; Arena, Emanuela; Prezzavento, Orazio; Amata, Emanuele; Marrazzo, Agostino | |
| Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. | 1-gen-2018 | Dichiara, M; Modica, Mn; Leonardi, C; Margani, F; Ciaffaglione, V; Fallica, An; Floresta, G; Gentile, D; Cosenza, J; Pittalà, V. | file da validare |
| Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents | 1-gen-2019 | Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, Guglielmo; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino | |
| Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors | 1-gen-2019 | Intagliata, Sebastiano; Salerno, Loredana; Ciaffaglione, Valeria; Leonardi, Carmen; Fallica, ANTONINO NICOLO'; Carota, Giuseppe; Amata, Emanuele; Marrazzo, Agostino; Pittalà, Valeria; Romeo, Giuseppe | |
| Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region | 1-gen-2020 | Floresta, Giuseppe; Fallica, Antonino N.; Romeo, Giuseppe; Sorrenti, Valeria; Salerno, Loredana; Rescifina, Antonio; Pittalà, Valeria | |
| The potential role of sildenafil in cancer management through epr augmentation | 1-gen-2021 | Haider, M.; Elsherbeny, A.; Pittala, V.; Fallica, A. N.; Alghamdi, M. A.; Greish, K. | |
| Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective | 1-gen-2021 | Fallica, Antonino N; Pittalà, Valeria; Modica, Maria N; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Helal, Mohamed A; Intagliata, Sebastiano | |
| From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes | 1-gen-2021 | Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V. | |
| Growing the molecular architecture of imidazole-like ligands in HO-1 complexes | 1-gen-2021 | Floresta, G.; Fallica, A. N.; Salerno, L.; Sorrenti, V.; Pittala, V.; Rescifina, A. | |
| Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation | 1-gen-2021 | Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S. | |
| Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity | 1-gen-2021 | Fallica, A. N.; Sorrenti, V.; D'Amico, A. G.; Salerno, L.; Romeo, G.; Intagliata, S.; Consoli, V.; Floresta, G.; Rescifina, A.; D'Agata, V.; Vanella, L.; Pittala, V. | |
| The Promise of Nanotechnology in Personalized Medicine | 1-gen-2022 | Alghamdi, M. A.; Fallica, A. N.; Virzi, N.; Kesharwani, P.; Pittala, V.; Greish, K. | |
| Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects | 1-gen-2022 | Fallica, Antonino N; Ciaffaglione, Valeria; Modica, Maria N; Pittalà, Valeria; Salerno, Loredana; Amata, Emanuele; Marrazzo, Agostino; Romeo, Giuseppe; Intagliata, Sebastiano | |
| Targeting del sistema enzimatico dell'eme ossigenasi come nuovo approccio nella terapia antitumorale | 8-apr-2022 | Fallica, ANTONINO NICOLO' | |
| Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections | 1-gen-2023 | Virzi, N. F.; Fallica, A. N.; Romeo, G.; Greish, K.; Alghamdi, M. A.; Patane, S.; Mazzaglia, A.; Shahid, M.; Pittala, V. | |
| Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer | 1-gen-2024 | Consoli, Valeria; Fallica, Antonino N.; Virzì, Nicola F.; Salerno, Loredana; Intagliata, Sebastiano; Sorrenti, Valeria; Greish, Khaled; Giuffrida, Alessandro; Vanella, Luca; Pittalà, Valeria |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile